A reversible posterior leukoencephalopathy syndrome
- PMID: 8559202
- DOI: 10.1056/NEJM199602223340803
A reversible posterior leukoencephalopathy syndrome
Abstract
Background and methods: In some patients who are hospitalized for acute illness, we have noted a reversible syndrome of headache, altered mental functioning, seizures, and loss of vision associated with findings indicating predominantly posterior leukoencephalopathy on imaging studies. To elucidate this syndrome, we searched the log books listing computed tomographic (CT) and magnetic resonance imaging (MRI) studies performed at the New England Medical Center in Boston and Hôpital Sainte Anne in Paris; we found 15 such patients who were evaluated from 1988 through 1994.
Results: Of the 15 patients, 7 were receiving immunosuppressive therapy after transplantation or as treatment for aplastic anemia, 1 was receiving interferon for melanoma, 3 had eclampsia, and 4 had acute hypertensive encephalopathy associated with renal disease (2 with lupus nephritis, 1 with acute glomerulonephritis, and 1 with acetaminophen-induced hepatorenal failure). Altogether, 12 patients had abrupt increases in blood pressure, and 8 had some impairment of renal function. The clinical findings included headaches, vomiting, confusion, seizures, cortical blindness and other visual abnormalities, and motor signs. CT and MRI studies showed extensive bilateral white-matter abnormalities suggestive of edema in the posterior regions of the cerebral hemispheres, but the changes often involved other cerebral areas, the brain stem, or the cerebellum. The patients were treated with antihypertensive medications, and immunosuppressive therapy was withdrawn or the dose was reduced. In all 15 patients, the neurologic deficits resolved within two weeks.
Conclusions: Reversible, predominantly posterior leukoencephalopathy may develop in patients who have renal insufficiency or hypertension or who are immunosuppressed. The findings on neuroimaging are characteristic of subcortical edema without infarction.
Comment in
-
A reversible posterior leukoencephalopathy syndrome.N Engl J Med. 1996 Jun 27;334(26):1743; author reply 1746. doi: 10.1056/NEJM199606273342613. N Engl J Med. 1996. PMID: 8637524 No abstract available.
-
A reversible posterior leukoencephalopathy syndrome.N Engl J Med. 1996 Jun 27;334(26):1744-5; author reply 1746. N Engl J Med. 1996. PMID: 8637525 No abstract available.
-
A reversible posterior leukoencephalopathy syndrome.N Engl J Med. 1996 Jun 27;334(26):1745; author reply 1746. N Engl J Med. 1996. PMID: 8637526 No abstract available.
-
A reversible posterior leukoencephalopathy syndrome.N Engl J Med. 1996 Jun 27;334(26):1745; author reply 1746. N Engl J Med. 1996. PMID: 8637527 No abstract available.
-
Cancer immunotherapy-induced posterior reversible encephalopathy syndrome in an ED.Am J Emerg Med. 2017 Apr;35(4):663.e1-663.e2. doi: 10.1016/j.ajem.2016.10.069. Epub 2016 Oct 29. Am J Emerg Med. 2017. Retraction in: Am J Emerg Med. 2018 Nov;36(11):2137. doi: 10.1016/j.ajem.2018.07.007. PMID: 27836313 Retracted. No abstract available.
-
Reversible Posterior Leukoencephalopathy Syndrome after Eribulin Mesylate Chemotherapy for Breast Cancer.Breast J. 2017 Jul;23(4):487-488. doi: 10.1111/tbj.12776. Epub 2017 Jan 31. Breast J. 2017. PMID: 28139871 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical